ARTICLE | Product Development
Hidden consequences of COVID-19: Why small biotechs can’t just wait this one out
Commentary: Small biotechs should prepare for the knock-on effects of COVID-19 that last beyond the crisis
March 4, 2020 10:33 PM UTC
Updated on Apr 4, 2020 at 6:35 AM UTC
It’s still anyone’s guess as to how long the COVID-19 outbreak will take to peak, let alone wane after that. But small biotechs could see knock-on effects that play out over a longer time frame than the course of the virus’ spread. Anticipating those, and acting pre-emptively, might be the difference between emerging unscathed and spending years making up for lost time.
The pressing question is what is the tipping point at which the disruptions to daily business turn into long-term problems...